ReNeuron avoids stem cell problem

By Peter McCready Stem-cell research in the US that failed to treat Parkinson's disease is funda...

By Peter McCready Stem-cell research in the US that failed to treat Parkinson's disease is fundamentally different to the type of treatment developed by UK-listed ReNeuron, according to observers in London. A joint article by scientists from Columbia University, New York, and the University of Colorado published in the New England Journal of Medicine said clinical trials using foetal implants in the brain had produced irreversible side-effects. Larissa Thomas, an analyst at WestLB Panmure, said the US search for a Parkinson's treatment uses multiple individual cells from more than one f...